The mechanism of high mobility group box-1 protein and its bidirectional regulation in tumors
-
Published:2023-10-26
Issue:
Volume:
Page:
-
ISSN:2831-090X
-
Container-title:Biomolecules and Biomedicine
-
language:
-
Short-container-title:Biomol Biomed
Author:
Tian Zhongjia,Zhu Lin,Xie Yutong,Hu Huan,Ren Qunli,Liu Jianguo,Wang Qian
Abstract
High mobility protein B1 (HMGB1) is a nonhistone chromatin-related protein widely found in eukaryotic cells. It is involved in the transcription, replication and repair of DNA to maintain nuclear homeostasis. It participates in cell growth, differentiation and signal transduction. Recent studies showed that HMGB1 has a bidirectional regulatory effect on tumors by regulating TLR4/MYD88/NF-κB and RAGE/AMPK/mTOR signaling pathways. On one hand, it is highly expressed in a variety of tumors, promoting tumor proliferation and invasion, whilst on the other hand, it induces autophagy and apoptosis of tumor cells and stimulates tumor-infiltrating lymphocytes to produce anti-tumor immune response. At present, HMGB1 could be used as a target to regulate the drug-resistance and prognostication in cancer. Clinical applications of HMGB1 in cancer need further in-depth studies.
Publisher
Association of Basic Medical Sciences of FBIH